Abstract: Provided is a multiply configurable modular study carrel. Also provided is a study carrel having at least one locking post; and at least one panel affixed to the locking post. Also provided is a study carrel including a panel having a bottom edge, and a first and second panel brace; the first and second panel brace supporting the panel such that the bottom edge of the panel is perpendicular to the first and second panel braces. Also provided is study carrel having a first panel, and a second panel; the first panel having a slot in the middle of the bottom edge; the second panel having a slot in the middle of the top edge; and the slot of the first panel seated in the slot of the second panel such that the first and second panel are perpendicularly affixed to each other.

Abstract: A system and method for process data management and organization is provided. An embodiment includes an apparatus for updating a process. The apparatus includes a storage device capable of storing a prospect database. The apparatus is operable to receive a prospect record from the stored prospect database. Once the prospect record is obtained, the apparatus can determine a process stage associated with the prospect record, and identify an available action associated with the stage which can be received from the storage device. The apparatus is operable to trigger the performance of the determined action and receive resulting data. Accordingly, the stage associated with the prospect record can be updated by the apparatus.

Abstract: The invention provides a synthetic polypeptide of Formula I?: or an amide, an ester or a salt thereof, wherein X1, X2, X3, X4, X5, X6, X7, X8, X9, X10, X11, X12 and X13 are defined herein. The polypeptides are agonist of the APJ receptor. The invention also relates to a method for manufacturing the polypeptides of the invention, and its therapeutic uses such as treatment or prevention of acute decompensated heart failure (ADHF), chronic heart failure, pulmonary hypertension, atrial fibrillation, Brugada syndrome, ventricular tachycardia, atherosclerosis, hypertension, restenosis, ischemic cardiovascular diseases, cardiomyopathy, cardiac fibrosis, arrhythmia, water retention, diabetes (including gestational diabetes), obesity, peripheral arterial disease, cerebrovascular accidents, transient ischemic attacks, traumatic brain injuries, amyotrophic lateral sclerosis, burn injuries (including sunburn) and preeclampsia.

Abstract: The present invention provides a method of treating a HCV infection in a subject in need thereof by administering a compound of Formula I: or pharmaceutically acceptable salts thereof or stereoisomers thereof.

Abstract: A nanostructure includes a plurality of metal nanoblades positioned with one edge on a substrate. Each of the plurality of metal nanoblades has a large surface area to mass ratio and a width smaller than a length. A method of storing hydrogen includes coating a plurality of magnesium nanoblades with a hydrogen storage catalyst and storing hydrogen by chemically forming magnesium hydride with the plurality of magnesium nanoblades.

Abstract: The present application describes organic compounds of a general formula: and salts, and isomers thereof, wherein R, R2 and R3 are defined in the specification. The compounds are useful for treating a gram-negative bacterial infection.

Abstract: A publication including a plurality of pairs of pages, with the pair of pages comprised of a removable page and non-removable page. The removable page has a perforated edge, an adhesive edge opposite the perforated edge and a printable surface. The non-removable page has a printable surface. The pairs of pages are arranged such that alternate pages are removable and can be removed without harming the publication or the non-removable pages. The removable pages can be arranged to form an image larger than the publication itself and removable attached to a surface through the adhesive edge.

Abstract: A nanostructure includes a plurality of metal nanoblades positioned with one edge on a substrate. Each of the plurality of metal nanoblades has a large surface area to mass ratio and a width smaller than a length. A method of storing hydrogen includes coating a plurality of magnesium nanoblades with a hydrogen storage catalyst and storing hydrogen by chemically forming magnesium hydride with the plurality of magnesium nanoblades.

Abstract: The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of human diseases.

Abstract: The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of human diseases.

Abstract: The present application describes organic compounds of the Formula I that are useful for the treatment, prevention and/or amelioration of human diseases.

Abstract: The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of human diseases.

Abstract: The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of human diseases.

Abstract: The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of human diseases.

Abstract: The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of human diseases.

Abstract: The present application describes macrocyclic compounds of formula (I) with NS3 protease inhibitory activity for treating hepatitis C virus infection.

Abstract: A nanostructure includes a plurality of metal nanoblades positioned with one edge on a substrate. Each of the plurality of metal nanoblades has a large surface area to mass ratio and a width smaller than a length. A method of storing hydrogen includes coating a plurality of magnesium nanoblades with a hydrogen storage catalyst and storing hydrogen by chemically forming magnesium hydride with the plurality of magnesium nanoblades.

Abstract: The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of human diseases.

Abstract: The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of human diseases.

Abstract: The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of human diseases.